<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>The New England Journal of Medicine: Search Results in Dermatology</title>
        <description>The New England Journal of Medicine (NEJM) RSS feed -- Search Results in Dermatology. NEJM (https://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.</description>
        <link>https://www.nejm.org/action/showPodcastsFeeds</link>
        <generator>NEJM Group</generator>
        <lastBuildDate>Fri, 17 Apr 2026 10:33:43 GMT</lastBuildDate>
        <copyright>2026 NEJM Group</copyright>
        <language>en-us</language>
        <ttl>1440</ttl>
        <atom:link href="https://onesearch-rss.nejmgroup-production.org/specialty/dermatology" rel="self" type="application/rss+xml"/>
        <item>
            <title>Adult-Onset Still’s Disease</title>
            <description>A 27-year-old woman presented with a 2-week history of joint pain, fever, sore throat, and a nonpruritic rash that worsened during fever. Laboratory tests showed an elevated ESR and elevated C-reactive protein and ferritin levels.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMicm2514594?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMicm2514594</guid>
            <dc:creator>Gabrielle Cognacq, Richard Stratton</dc:creator>
            <dc:date>2026-04-16</dc:date>
            <dc:title>Adult-Onset Still’s Disease</dc:title>
        </item>
        <item>
            <title>Endovascular Therapy for Post-Thrombotic Syndrome — A Randomized Trial</title>
            <description>Among patients with moderate or severe PTS, the addition of endovascular therapy to standard care resulted in less severe PTS and better quality of life at 6 months than standard care alone but with a higher risk of bleeding.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMoa2519001?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMoa2519001</guid>
            <dc:creator>Suresh Vedantham, Susan R. Kahn, William A. Marston, Ido Weinberg, Akhilesh K. Sista, Elizabeth A. Magnuson, David J. Cohen, Suman M. Wasan, Mahmood K. Razavi, Samuel Z. Goldhaber, Kristen M. Sanfilippo, Anthony J. Comerota, Ezana M. Azene, Cassius Iyad Ochoa Chaar, Daniel A. Leung, K. Pallav Kolli, Sanjeeva P. Kalva, Nassir Rostambeigi, Ajinkya Desai, Kush R. Desai, Alfonso J. Tafur, Bhavraj Khalsa, Elaine Majerus, Borong Wang, Yang Wang, Patricia Nieters, Mary Clare Derfler, Angela Oliver, Cassandra Hardy, Riyaz Bashir, Ronald Winokur, Natalie Weger, Minhaj S. Khaja, Aditya Sharma, Naganathan Mani, Pavan Kavali, Siddhant Thukral, Leslie L. Lake, Kathryn Mikkelsen, Sameer Parpia, the C-TRACT Trial Investigators*</dc:creator>
            <dc:date>2026-04-13</dc:date>
            <dc:title>Endovascular Therapy for Post-Thrombotic Syndrome — A Randomized Trial</dc:title>
        </item>
        <item>
            <title>Stenting for Post-Thrombotic Syndrome — A Step Forward</title>
            <description>Post-thrombotic syndrome is the most common chronic complication of deep-vein thrombosis (DVT), affecting 20 to 50% of patients with DVT and causing debilitating symptoms involving the limbs — including pain, swelling, skin changes, and venous ulcers — that substantially reduce quality of life and impose considerable socioeconomic burden.1 ...</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMe2603048?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMe2603048</guid>
            <dc:creator>Ronald Luiz Gomes Flumignan, Luís Carlos Uta Nakano</dc:creator>
            <dc:date>2026-04-13</dc:date>
            <dc:title>Stenting for Post-Thrombotic Syndrome — A Step Forward</dc:title>
        </item>
        <item>
            <title>Celiac Disease</title>
            <description>This review summarizes the epidemiology, diagnosis, and management of celiac disease and highlights serologic testing, biopsy confirmation, associated autoimmune conditions, and a gluten-free diet as treatment.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMcp2415548?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMcp2415548</guid>
            <dc:creator>Joseph A. Murray, Steffen Husby</dc:creator>
            <dc:date>2026-04-09</dc:date>
            <dc:title>Celiac Disease</dc:title>
        </item>
        <item>
            <title>Necrolytic Migratory Erythema</title>
            <description>An 83-year-old woman with worsening type 2 diabetes presented with a 6-month history of painful rash. Hyperpigmented plaques with coalescing erosions and blisters were seen. Abdominal CT revealed a mass in the tail of the pancreas.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMicm2516331?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMicm2516331</guid>
            <dc:creator>Jia-An Hung, Ming-Chieh Lin</dc:creator>
            <dc:date>2026-04-09</dc:date>
            <dc:title>Necrolytic Migratory Erythema</dc:title>
        </item>
        <item>
            <title>Minocycline-Induced Hyperpigmentation</title>
            <description>A 68-year-old woman with rosacea presented with a 6-week history of dark patches on the skin of her arms and legs. Two weeks before the onset of the skin changes, she had started taking minocycline daily.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMicm2513782?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMicm2513782</guid>
            <dc:creator>Aarti Maharaj, Michael Omar</dc:creator>
            <dc:date>2026-04-02</dc:date>
            <dc:title>Minocycline-Induced Hyperpigmentation</dc:title>
        </item>
        <item>
            <title>A Phase 3 Trial of Brepocitinib in Dermatomyositis</title>
            <description>In a trial of brepocitinib in adults with dermatomyositis, the 30-mg dose (but not the 15-mg dose) led to greater improvement on a composite myositis index at 52 weeks than placebo. Serious infections were more frequent with the 30-mg dose.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMoa2503531?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMoa2503531</guid>
            <dc:creator>Ruth Ann Vleugels, Julie J. Paik, Iazsmin Bauer Ventura, Aaron R. Mangold, Prateek C. Gandiga, Anna Haemel, Hector Chinoy, Yessar M. Hussain, Kumaraswamy Sivakumar, Zoltan Griger, Eun Bong Lee, Francisca Bozan, Chung-Yuan Hsu, Alisa Femia, Mazen M. Dimachkie, Michelle S. Min, Tahseen Mozaffar, Christina Charles-Schoeman, David R. Fernandez, Oluwakemi Onajin, Raquel Marques, Galina Marder, Floranne Ernste, Elena Schiopu, Jason Sluzevich, David Pearson, Stephen Lindsey, Michael Luggen, Michael R. Bubb, Erin Boh, Rashmi Maganti, Latisha Heinlen, Katharina S. Shaw, Matthew D. Cascino, Paul N. Mudd Jr., Jiri Vencovsky, Anthony P. Fernandez, David Fiorentino, Lisa Christopher-Stine, Victoria P. Werth, Rohit Aggarwal, the VALOR Investigators*</dc:creator>
            <dc:date>2026-03-28</dc:date>
            <dc:title>A Phase 3 Trial of Brepocitinib in Dermatomyositis</dc:title>
        </item>
        <item>
            <title>Eczema Herpeticum</title>
            <description>A 33-year-old pregnant woman with previously controlled atopic dermatitis presented with 3 days of fever and an itchy, painful rash. Erythematous vesiculopapular lesions were noted on the face, neck, chest, and arms.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMicm2516038?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMicm2516038</guid>
            <dc:creator>Heba H.A.H.Y. AlBaloul, Carson K.L. Lo</dc:creator>
            <dc:date>2026-03-26</dc:date>
            <dc:title>Eczema Herpeticum</dc:title>
        </item>
        <item>
            <title>Vulvar Melanoma with Vaginal Extension</title>
            <description>A 49-year-old woman presented with a 6-month history of an itchy lump on her vulva. Examination showed a painless purple mass originating in the labia minora on the left side.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMicm2509511?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMicm2509511</guid>
            <dc:creator>Francisco Javier Castro-Apodaca, Adrian Canizalez-Roman</dc:creator>
            <dc:date>2026-03-12</dc:date>
            <dc:title>Vulvar Melanoma with Vaginal Extension</dc:title>
        </item>
        <item>
            <title>Trigeminal Trophic Syndrome</title>
            <description>A woman presented with a 1-year history of a crawling sensation on her chin that caused her to scratch the area. An irregular ulcer was present on the right side of her chin, with reduced sensation around the mouth, lip, and chin.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMicm2512031?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMicm2512031</guid>
            <dc:creator>Anna Kersh, Janine Lobo Lopes</dc:creator>
            <dc:date>2026-03-05</dc:date>
            <dc:title>Trigeminal Trophic Syndrome</dc:title>
        </item>
        <item>
            <title>The Growing Success of Medicare Drug-Price Negotiation</title>
            <description>Medicare will achieve greater savings on the 15 drugs in its second round of price negotiations than it did in the first round. Despite new challenges, the effort should continue to pay growing dividends.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMp2517584?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMp2517584</guid>
            <dc:creator>Benjamin N. Rome, Aaron S. Kesselheim</dc:creator>
            <dc:date>2026-02-26</dc:date>
            <dc:title>The Growing Success of Medicare Drug-Price Negotiation</dc:title>
        </item>
        <item>
            <title>Primary Measles Infection</title>
            <description>A previously healthy man presented with a 5-day history of fever, nausea, and vomiting and a 2-day history of an itchy rash. Examination showed an exanthem consisting of minute macules and subtly elevated papules.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMicm2514397?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMicm2514397</guid>
            <dc:creator>Maximilian Lammer, Barbara C. Böckle</dc:creator>
            <dc:date>2026-02-26</dc:date>
            <dc:title>Primary Measles Infection</dc:title>
        </item>
        <item>
            <title>Majocchi’s Granuloma</title>
            <description>A high-school wrestler presented with an itchy rash that had worsened despite topical antifungal and glucocorticoid treatment. A circular, scaly plaque with papules, nodules, and pustules was seen on his calf.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMicm2509457?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMicm2509457</guid>
            <dc:creator>Ciara A. Maguire, Seth J. Orlow</dc:creator>
            <dc:date>2026-02-19</dc:date>
            <dc:title>Majocchi’s Granuloma</dc:title>
        </item>
        <item>
            <title>Toxic Erythema of Chemotherapy</title>
            <description>A 55-year-old woman with invasive ductal carcinoma presented with a rash that had developed after a round of chemotherapy and had worsened and spread to her axillae, groin, and popliteal fossae after several additional rounds.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMicm2513411?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMicm2513411</guid>
            <dc:creator>Shihua Ling, Xia Dou</dc:creator>
            <dc:date>2026-01-29</dc:date>
            <dc:title>Toxic Erythema of Chemotherapy</dc:title>
        </item>
        <item>
            <title>Nivolumab for Resected Stage III or IV Melanoma at 9 Years</title>
            <description>In resected stage III or IV melanoma, nivolumab improved 9-year recurrence-free survival as compared with ipilimumab (44% vs. 37%), with no new late adverse events and fewer subsequent therapies needed.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMoa2504966?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMoa2504966</guid>
            <dc:creator>Paolo A. Ascierto, Michele Del Vecchio, Barbara Merelli, Helen Gogas, Ana M. Arance, Stéphane Dalle, Charles Lance Cowey, Michael Schenker, Caroline Gaudy-Marqueste, Jacopo Pigozzo, Iván Márquez-Rodas, Marcus O. Butler, Anna Maria Di Giacomo, Oleg Gligich, Luis De La Cruz-Merino, Petr Arenberger, Victoria Atkinson, Paul Nathan, Andrew Hill, Michael Millward, Leslie A. Fecher, Nikhil I. Khushalani, Paola Queirolo, Raheela Soomro, Dhanrajsinh Rathod, Margarita Askelson, Melanie Pe Benito, Devanand Joseph, James Larkin</dc:creator>
            <dc:date>2026-01-22</dc:date>
            <dc:title>Nivolumab for Resected Stage III or IV Melanoma at 9 Years</dc:title>
        </item>
        <item>
            <title>Changing Role of Adjuvant Therapy in Stage III Melanoma</title>
            <description>The concept of adjuvant therapy for cancer was developed at a time when systemic cancer treatment was limited to cytotoxic chemotherapy that could only be administered intermittently but rarely resulted in a complete response. Skipper1 and others hypothesized that if treatment were started early in the disease course,...</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMe2514054?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMe2514054</guid>
            <dc:creator>Paul B. Chapman, Jedd D. Wolchok</dc:creator>
            <dc:date>2026-01-22</dc:date>
            <dc:title>Changing Role of Adjuvant Therapy in Stage III Melanoma</dc:title>
        </item>
        <item>
            <title>Prurigo Pigmentosa</title>
            <description>A 20-year-old man presented with an itchy rash 2 months after starting a ketogenic diet. Examination showed symmetric, erythematous papules and underlying reticulated hyperpigmentation on the chest, neck, and shoulders.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMicm2514242?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMicm2514242</guid>
            <dc:creator>Chin-Yu Lee, Stephen Chu-Sung Hu</dc:creator>
            <dc:date>2026-01-22</dc:date>
            <dc:title>Prurigo Pigmentosa</dc:title>
        </item>
        <item>
            <title>Primary Palmoplantar Pustulosis</title>
            <description>A 60-year-old man with a 30-pack-year smoking history presented with a 2-year history of a painful rash on his palms and soles. Numerous pustules with erosions, crusting, and surrounding erythema were noted.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMicm2505935?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMicm2505935</guid>
            <dc:creator>Leila Shayegan, Ruth Ann Vleugels</dc:creator>
            <dc:date>2026-01-15</dc:date>
            <dc:title>Primary Palmoplantar Pustulosis</dc:title>
        </item>
        <item>
            <title>Granulomatosis with Polyangiitis</title>
            <description>A 20-year-old woman presented with 9 days of pain and decreased vision in the right eye, as well as 2 weeks of a rash and gum swelling. Fever, dyspnea, and hemoptysis developed.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMicm2513376?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMicm2513376</guid>
            <dc:creator>Jian Zhu, Chenghao Fu</dc:creator>
            <dc:date>2026-01-15</dc:date>
            <dc:title>Granulomatosis with Polyangiitis</dc:title>
        </item>
        <item>
            <title>Atretic Cephalocele</title>
            <description>A 5-week-old boy was brought to the hospital with a painful scalp lump that had been present since birth. On examination, there was a tense, nonpulsatile round mass on the occiput surrounded by a ring of dark, coarse hair.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMicm2507483?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMicm2507483</guid>
            <dc:creator>James Ralph, Fiona Browne</dc:creator>
            <dc:date>2026-01-08</dc:date>
            <dc:title>Atretic Cephalocele</dc:title>
        </item>
    </channel>
</rss>